Events

Company Also Launches Disease Awareness Campaign to Raise Awareness Among Physicians About the Silent Damage Caused by Sickle Cell Disease

Expedeon AG announced that the Annual General Meeting held in Heidelberg yesterday, July 09, 2019, approved all management proposals.

BIOXYTRAN, INC. announced that it was invited to attend the 19th annual New York Venture Summit, presented by youngStartup Ventures on July 9th and July 10th.

Ascension Healthcare plc announces it will be attending the 27th International Society of Thrombosis and Haemostasis Congress, taking place in Melbourne, Australia, from Saturday 6th July to Wednesday 10th July.

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicines, presented the research data on the treatment of relapsed or refractory extranodal NK/T cell lymphoma with sintilimab, co-developed with Eli Lilly and Company and key data from six other clinical studies were presented at the 55th Annual Meeting of the American Society of Clinical Oncology by oral presentation and posters.

Even with a holiday week, July 4, there were a number of clinical trial reports. Here’s a look.

BioArctic AB to publish the company’s Interim Report for the period January – June 2019 on Thursday, July 11, 2019 at 08:00 a.m. CET.

The explosion, which is still being investigated, happened at Xumei Biotech Co. Ltd. in Weishi County, part of China’s Henan Province.

InvestAcure, PBC announced that NFL ‘super agent’ Leigh Steinberg and former Vice Chairman of the NASDAQ David Weild VI will host and keynote at the Cure Coin Awards Reception on July 15, during the Alzheimer’s Association International Conference in Los Angeles.

Exicure, Inc., a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs, announced data from a preclinical study evaluating the biodistribution of SNAs in the non-human primate central nervous system.